Pandemic Preparedness Strategy

Objectives

The strategy sets a United Kingdom-wide, whole-of-government and whole-of-society framework for preparing for pandemics through to 2030. It aims to protect lives, reduce unequal health, social and economic impacts, maintain essential services and critical national infrastructure, and build adaptable capabilities for pathogens with any of five principal transmission routes.[1][2][3][4]It applies a multi-hazard One Health approach linking human, animal, plant and environmental health.[3]

• Plan for a whole-system response through tested cross-government, national, regional and local arrangements, clear roles, command structures, recovery planning and updated legislation.[5][6][7]
• Protect communities and build trust through equitable, evidence-informed public health measures, accessible communications, targeted support for vulnerable groups, and scalable case, contact, outbreak-management and testing services.[5][8][9][10]
• Improve access to clinical countermeasures by accelerating research, diagnostics, vaccines and therapeutics; maintaining stockpiles and manufacturer agreements; strengthening domestic production; and ensuring equitable deployment.[5][11][12][13]
• Strengthen surveillance and data through activatable systems, representative studies, genomic sequencing, metagenomics, wastewater monitoring, international intelligence and timely analysis for decisions at every level.[5][14][15][16]
• Support the National Health Service, adult social care and public health systems to prevent illness, respond and scale during a pandemic while maintaining routine, maternity, neonatal, mental health, screening and community services.[5][17][18][19]

Preparedness is designed for scenarios that differ from COVID-19. The National Risk Register 2025 reasonable worst-case respiratory-pandemic scenario projects illness in half of the United Kingdom population, 1.34 million hospitalisations and 840,000 deaths without mitigation.[2]The framework therefore covers the full pandemic life cycle, from prevention and early containment through mitigation, recovery and renewed preparedness.[3][4]

Implementation

Implementation is led by the Department of Health and Social Care, working with the Cabinet Office, UK Health Security Agency, NHS England, devolved governments, other departments, executive agencies, local government, public health bodies, industry, academia, civil society and communities.[4][20]Pandemic preparedness and response are primarily devolved, so the four United Kingdom governments retain responsibility for their own approaches while collaborating on cross-UK capabilities, including surveillance, procurement and shared data platforms.[21]

• Use the Cabinet Office Pandemic Concept of Operations and existing cross-government governance arrangements to define roles, co-ordinate decisions, provide assurance and manage whole-system emergencies.[22][7]
• Maintain an Enduring Pandemic Taskforce, activated for a whole-system emergency, to broker collective policy agreement and support departments managing cross-cutting impacts.[7]
• Require departments and local responders to maintain, test and pre-cost pandemic plans covering service continuity, critical infrastructure, workforce absence, community protection, supply chains and health and care support.[23][6][22]
• Develop an adaptable All Pandemic Hazards Bill by March 2027, using modular powers that can be selected according to the pathogen, transmission route and geographical need.[24][8]
• Review critical-worker definitions, frameworks for identifying people at risk, and prioritisation principles for scarce testing, personal protective equipment and vaccines.[7][25]
• Strengthen personal protective equipment preparedness through evidence-based stockpile targets, dynamic stockpiling, supply contracts, annual deployment-plan testing and a cross-government model for procurement and prioritisation during shortages.[26][24]
• Develop community-centred communication and response arrangements through local authorities, voluntary, community and social enterprise organisations, faith groups, health and care providers and community representatives, including multilingual, accessible and non-digital routes.[9][10]
• Scale diagnostics through industry partnerships, laboratory integration, reserve workforce planning, stocks of testing inputs and clear mobilisation triggers, while applying a United Kingdom Health Security Agency-led prioritisation model.[27][14]
• Strengthen health and care resilience through an adult social care pandemic action plan by 2027, hospital-discharge planning, community-based and digital care, surge capacity, workforce measures, infection prevention and control training, and supply-chain resilience for medicines and medical devices.[17][28][29][18]

International delivery includes collaboration with the Republic of Ireland, European Union, World Health Organization, multilateral organisations, overseas public health bodies and life-sciences partners to improve surveillance, contain outbreaks at source, protect supply chains and develop countermeasures.[21][16]The strategy also supports the World Health Organization Pandemic Agreement and global preparedness investment.[21]

Delivery is phased through short-term actions to March 2027, medium-term actions from 2027 to 2028 and long-term actions from 2028 to 2030.[20][30]It will be refined using Exercise Pegasus, the UK Covid-19 Inquiry, future inquiry recommendations, emerging research, technology and evidence; the full Exercise Pegasus report is expected by winter 2026, and a strategy review is scheduled for 2028.[5][30][31]

Funding includes around £1 billion for health protection during the Spending Review 2025 period, £250 million for a biosecurity centre in Harlow, £160 million over five years for the Coalition for Epidemic Preparedness Innovations, and up to £520 million in Life Sciences Innovative Manufacturing Fund capital grants from 2025 to 2030.[4][32][13]The source does not provide a complete costed implementation plan, consolidated performance indicators or a quantified funding-gap assessment.[4][31]

Monitoring & Evaluation

Preparedness monitoring is centred on adaptable surveillance, timely data and analysis, exercising, evidence review and cross-government assurance. The strategy uses five strategic outcomes to assess capabilities, but does not establish a consolidated indicator set, quantitative targets, common reporting timetable or independent evaluation framework.[5][4]

• Maintain diverse, scalable surveillance systems, population studies and sample groups to detect pathogens, understand transmission and vulnerabilities, monitor genomic change, and evaluate vaccines, therapeutics and community measures.[14][15]
• Integrate health, animal, plant, wastewater, border, community and international surveillance through a One Health approach and the National Biosurveillance Network.[14]
• Use laboratory wastewater surveillance, including aircraft-sampling evaluation and a Ministry of Defence pilot, as an early-warning source alongside wider domestic surveillance.[14]
• Strengthen data sharing between the National Health Service, UK Health Security Agency and local systems, supported by common data requirements, legal frameworks, secure access, public dashboards and transparent publication of appropriate official statistics.[15][16][17]
• Use live evaluation, impacts data, modelling, behavioural science and social research to assess whether public-health measures and communications are understood, accepted and effective, and to adapt policy to real-world effects and inequalities.[3][33][9][10]
• Test plans through the National Exercising Programme, departmental exercises and Exercise Pegasus, and revise planning, guidance, governance and local arrangements as risks, outbreaks and evidence develop.[22][7]
• Review England’s personal protective equipment stockpile targets regularly and test deployment plans at least annually, incorporating lessons from Exercise Pegasus into regional and local planning.[26]
• Assess testing, diagnostic assays, clinical countermeasures, workforce capability, specialist capacity, supply-chain resilience and health-service capacity through exercises, expert review, trials and operational testing.[32][12][13][29][18]
• Provide implementation assurance through existing cross-government governance arrangements, with the Department of Health and Social Care leading delivery alongside the Cabinet Office, UK Health Security Agency, NHS England, other departments and devolved governments.[4]
• Retain public-spending accountability to Parliament during a pandemic.[23]

Time-bound review commitments include assessing data, analysis and modelling capability by March 2027; publishing evidence reviews on community protection measures across transmission routes by 2030; reviewing the overall strategy in 2028; and considering future findings from the United Kingdom COVID-19 Inquiry and the full Exercise Pegasus report expected by winter 2026.[33][30][31]

Costing & Financing

Funding combines specified health-protection, research, manufacturing, surveillance and health-service investments with commitments to pre-cost departmental response plans. The available material does not provide a comprehensive pandemic-preparedness budget, costed delivery plan, recurrent expenditure profile, quantified funding gap or wider economic assumptions.[4][22][27][14]

• Provide around 1 billion pounds sterling for health protection during the Spending Review 2025 period, with subsequent funding subject to future spending reviews.[4]
• Invest 250 million pounds sterling during the current Parliament in a biosecurity centre at Harlow, Essex, planned to become fully operational by 2038.[4]
• Maintain annual National Institute for Health and Care Research investment of more than 606 million pounds sterling in relevant research infrastructure, and commit 80 million pounds sterling in 2025 to recommission Health Protection Research Units.[4]
• Support clinical-countermeasure development through a 160 million pounds sterling, five-year pledge to the Coalition for Epidemic Preparedness Innovations and a government partnership with Moderna involving investment of more than 1 billion pounds sterling.[32]
• Provide up to 520 million pounds sterling in capital grants from 2025 to 2030 through the Life Sciences Innovative Manufacturing Fund, alongside 29.6 million pounds sterling for the UK RNA Biofoundry and 1.3 million pounds sterling for wastewater pathogen-detection technologies.[13][14]
• Invest up to 600 million pounds sterling with the Wellcome Trust to establish a health-data research service under the 10 Year Health Plan for England.[16]
• Allocate up to 1.65 billion pounds sterling in financial year 2025 to 2026 for NHS performance improvements supporting resilience, including ambulance priorities, radiotherapy equipment and diagnostic capacity, and provide up to 120 million pounds sterling for dedicated mental health emergency departments and same-day specialist support.[19][34]
• Require departments to pre-cost pandemic plans so estimated response costs can inform crisis decisions, while HM Treasury is to publish 2026 guidance on temporary public-spending flexibilities consistent with medium-term fiscal sustainability.[22][23]
• Develop and evaluate options during 2026 to 2027 for targeted pandemic funding for adult social care, including potential funding routes through local authorities or directly to providers.[29]

Other resource measures include stockpiles and supply contracts for personal protective equipment, medicines, diagnostics and hygiene products; dynamic stockpiling intended to reduce waste and costs; commercial arrangements to expand testing; investment in digital and health-care infrastructure; and research funding routes for platform trials. Monetary allocations for these measures are generally not specified.[26][10][12][20]